ARTICLES BY JAMES MORRIS
-
5 Operational Priorities For Pharma Companies In The Wake Of COVID-197/20/2020
Consider Gilead’s ramp-up of remdesivir under FDA Emergency Use Authorization, or the efforts of companies racing to bring vaccines and therapeutics for COVID-19 through clinical development, safety and efficacy trials at speeds not seen before. The analogy of changing a tire while driving the vehicle is well known — now picture doing so at 7,000 rpm!
This website uses cookies to ensure you get the best experience on our website. Learn more